Cargando…

Long non-coding RNA growth arrest specific transcript 5 acts as a tumour suppressor in colorectal cancer by inhibiting interleukin-10 and vascular endothelial growth factor expression

Long non-coding RNAs (lncRNAs) are highly involved in diverse biological processes of human malignancies. The expression profile and underlying mechanism of lncRNA growth arrest specific transcript 5 (GAS5) in colorectal cancer (CRC) is poorly understood. In this study, we found that GAS5 was common...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Yuan, Li, Yan, Huang, Shengkai, He, Kun, Zhao, Mei, Lin, Hong, Li, Dongdong, Qian, Jiaming, Zhou, Caihong, Chen, Yuhua, Huang, Changzhi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5355130/ https://www.ncbi.nlm.nih.gov/pubmed/28099146 http://dx.doi.org/10.18632/oncotarget.14625

Ejemplares similares

Long non-coding RNA growth arrest-specific 5 (GAS5) acts as a tumor suppressor by promoting autophagy in breast cancer
por: Li, Guangping, et al.
Publicado: (2020)

MiR-494 acts as a tumor promoter by targeting CASP2 in non-small cell lung cancer
por: Zhang, Qiao, et al.
Publicado: (2019)

The UbL-UBA Ubiquilin4 protein functions as a tumor suppressor in gastric cancer by p53-dependent and p53-independent regulation of p21
por: Huang, Shengkai, et al.
Publicado: (2018)

Overexpression of the Ubiquilin-4 (UBQLN4) is Associated with Cell Cycle Arrest and Apoptosis in Human Normal Gastric Epithelial Cell Lines GES-1 Cells by Activation of the ERK Signaling Pathway
por: Huang, Shengkai, et al.
Publicado: (2018)

LncRNA MIR155HG Overexpression Promotes Proliferation, Migration, and Chemoresistance in Gastric Cancer Cells
por: Lin, Hong, et al.
Publicado: (2023)

The β-TrCP-FBXW2-SKP2 axis regulates lung cancer cell growth with FBXW2 acting as a tumour suppressor
por: Xu, Jie, et al.
Publicado: (2017)

Fibroblast Growth Factor—14 Acts as Tumor Suppressor in Lung Adenocarcinomas
por: Turkowski, Kati, et al.
Publicado: (2020)

Serum vascular endothelial growth factor load and interleukin-6 in cancer patients
por: O'Byrne, K J, et al.
Publicado: (2000)

Targeting of endothelial cells in brain tumours
por: Duan, Wenzhe, et al.
Publicado: (2023)

CDK5RAP3 acts as a tumour suppressor in gastric cancer through the infiltration and polarization of tumour-associated macrophages
por: Wang, Jia-Bin, et al.
Publicado: (2022)

Investigating the Influence of Growth Arrest Mechanisms on Tumour Responses to Radiotherapy
por: Colson, Chloé, et al.
Publicado: (2023)

Interleukin-6 Induces Vascular Endothelial Growth Factor-C Expression via Src-FAK-STAT3 Signaling in Lymphatic Endothelial Cells
por: Huang, Yu-Han, et al.
Publicado: (2016)

High-salt diet inhibits tumour growth in mice via regulating myeloid-derived suppressor cell differentiation
por: He, Wei, et al.
Publicado: (2020)

Dual Pathways to Tubular Morphogenesis of Vascular Endothelial Cells by Human Glioma Cells: Vascular Endothelial Growth Factor/Basic Fibroblast Growth Factor and Interleukin‐8
por: Wakabayashi, Yukihiro, et al.
Publicado: (1995)

Vascular endothelial growth receptor 1 acts as a stress-associated protein in the therapeutic response to thalidomide
por: Liu, Qin, et al.
Publicado: (2017)

Serum vascular endothelial growth factor load and interleukin-6 in cancer patients – reply
por: Salgado, R, et al.
Publicado: (2000)

Circulating levels of interleukin-8 and vascular endothelial growth factor in patients with carotid stenosis.
por: Lee, S. H., et al.
Publicado: (2001)

Low vascular endothelial growth factor and interleukin-8 in cerebrospinal fluid of suicide attempters
por: Isung, J, et al.
Publicado: (2012)

Interaction of the growth and tumour suppressor NORE1A with microtubules is not required for its growth-suppressive function
por: Moshnikova, Anna, et al.
Publicado: (2008)

Targeting Vascular endothelial growth factor A with soluble vascular endothelial growth factor receptor 1 ameliorates nerve injury-induced neuropathic pain
por: Peng, Zhe, et al.
Publicado: (2022)

Interleukin-17 and vascular endothelial growth factor: new biomarkers for the diagnosis of papillary thyroid carcinoma in patients with Hashimoto’s thyroiditis
por: Li, Shuiping, et al.
Publicado: (2022)

RNA helicase DHX15 acts as a tumour suppressor in glioma
por: Ito, Shingo, et al.
Publicado: (2017)

Vascular endothelial growth factor acts as an osteolytic factor in breast cancer metastases to bone
por: Aldridge, S E, et al.
Publicado: (2005)

Suppressor T cell growth and differentiation. Identification of a cofactor required for suppressor T cell function and distinct from interleukin 2
Publicado: (1984)

Serglycin‐induced interleukin‐1β from oesophageal cancer cells upregulate hepatocyte growth factor in fibroblasts to promote tumour angiogenesis and growth
por: Yan, Dongdong, et al.
Publicado: (2022)

Epigenetic inactivation of tumour suppressor coding and non-coding genes in human cancer: an update
por: Llinàs-Arias, Pere, et al.
Publicado: (2017)

Combining Mechanisms of Growth Arrest in Solid Tumours: A Mathematical Investigation
por: Colson, Chloé, et al.
Publicado: (2022)

Stromal interaction essential for vascular endothelial growth factor A-induced tumour growth via transforming growth factor-β signalling
por: Weidenaar, A C, et al.
Publicado: (2011)

Endothelial cell-derived interleukin-6 regulates tumor growth
por: Neiva, Kathleen G, et al.
Publicado: (2014)

Chrysin targets myeloid‐derived suppressor cells and enhances tumour response to anti‐PD‐1 immunotherapy
por: Li, Yinan, et al.
Publicado: (2022)

Regulation of vascular endothelial growth factor expression in human colon cancer by interleukin-1β
por: Akagi, Y, et al.
Publicado: (1999)

Clinical Relevance of Serum Vascular Endothelial Growth Factor and Interleukin-6 in Patients With Colorectal Cancer
por: Alzoghaibi, Mohammad
Publicado: (2011)

Clinical Relevance of Serum Vascular Endothelial Growth Factor and Interleukin-6 in Patients with Colorectal Cancer
por: Eldesoky, Ayman, et al.
Publicado: (2011)

Interleukin-6, vascular endothelial growth factor and transforming growth factor beta 1 in canine steroid responsive meningitis-arteritis
por: Maiolini, Arianna, et al.
Publicado: (2013)

Local acting Sticky-trap inhibits vascular endothelial growth factor dependent pathological angiogenesis in the eye
por: Michael, Iacovos P, et al.
Publicado: (2014)

Endothelial extracellular vesicles promote tumour growth by tumour‐associated macrophage reprogramming
por: Njock, Makon‐Sébastien, et al.
Publicado: (2022)

MiRNA-610 acts as a tumour suppressor to depress the cisplatin resistance in hepatocellular carcinoma through targeted silencing of hepatoma-derived growth factor
por: Xu, Yongqing, et al.
Publicado: (2019)

LHX6 acts as a novel potential tumour suppressor with epigenetic inactivation in lung cancer
por: Liu, W-b, et al.
Publicado: (2013)

The epithelial splicing regulator ESRP2 is epigenetically repressed by DNA hypermethylation in Wilms tumour and acts as a tumour suppressor
por: Legge, Danny, et al.
Publicado: (2021)

The coxsackievirus and adenovirus receptor acts as a tumour suppressor in malignant glioma cells
por: Kim, M, et al.
Publicado: (2003)

Cannot write session to /tmp/vufind_sessions/sess_mauotbn5h93g0q45u5gn41odeu